Can-Fite BioPharma (CANF) Invested Capital (2014)
Can-Fite BioPharma (CANF) posted Invested Capital of $29.1 million for Q4 2014.
Analysis
Can-Fite BioPharma (CANF) Invested Capital (2014) Analysis & Trends
Can-Fite BioPharma (CANF) has 1 years of Invested Capital data on file, last reported at $29.1 million in Q4 2014.
- For the quarter ending Q4 2014, Invested Capital changed N/A year-over-year to $29.1 million; the trailing twelve-month figure through Dec 2014 stood at $29.1 million (changed N/A YoY), and the FY2014 full-year result was $29.1 million, changed N/A from the prior year.
- Invested Capital was $29.1 million for Q4 2014 at Can-Fite BioPharma.
- In the past five years, Invested Capital ranged from a high of $29.1 million in Q4 2014 to a low of $29.1 million in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.77 Bn | 631.01 Bn | 17.26 Bn | 145.70 Bn |
| 2 | AbbVie | 447.56 Bn | 440.99 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 364.58 Bn | 357.44 Bn | 12.21 Bn | 159.97 Bn |
| 4 | Novartis Ag | 268.98 Bn | 261.29 Bn | 11.24 Bn | 51.53 Bn |
| 5 | Pfizer | 158.03 Bn | 146.33 Bn | 10.94 Bn | 148.69 Bn |
| 6 | Sanofi | 52.29 Bn | 44.91 Bn | 10.79 Bn | 106.05 Bn |
| 7 | Revolution Medicines | 43.18 Bn | 43.18 Bn | - | - |
| 8 | Incyte | 25.12 Bn | 20.58 Bn | 1.57 Bn | 6.38 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Can-Fite BioPharma | 1.83 Mn | -1.16 Mn | - | - |